GlobalDeal

InterMune

Biotechnology · Brisbane, Queensland, Australia

gene.com

About InterMune

InterMune is a values-driven organization that works to embody integrity, passion, accountability, creativity and teamwork in bringing new treatments and hope to patients and families around the world. Our focus is research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases, including idiopathic pulmonary fibrosis (IPF), a progressive, irreversible, unpredictable and ultimately fatal lung disease. Pirfenidone, the only medicine approved for IPF, is marketed by InterMune in the EU and Canada as Esbriet® and is currently in a Phase 3 clinical trial to support regulatory registration in the United States.

Find important safety information and patient resources for all of our currently marketed medicines.

Phone: (888) 835-2555

Company facts

Industry
Biotechnology
Sub-industries
Treatment Therapies, Pharmaceuticals
Location
Brisbane, Queensland, Australia
Employees
51–200
Revenue (USD)
50–100M
Founded
1998

Products and services

Open InterMune in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in Australia

All 645 Biotechnology companies in Australia →